ENTHERA

We are a biotech company building a pipeline of first-in-class biologics for several underserved autoimmune conditions, with a focus on Type 1 Diabetes (T1D) and Inflammatory Bowel Disease (IBD). Our aim is to develop disease-modifying treatments by preserving and re-establishing cell and organ function to revert the outcome of these conditions... By targeting the IGFBP3/TMEM219 axis and its dysregulation, we aim to provide safe and effective therapeutics for autoimmune diseases with high unmet medical need... We develop first-in-class biologics for several underserved autoimmune conditions. Our therapeutic approach aims to preserve and re-establish organ cell function, transforming the treatment paradigm for intractable autoimmune diseases.

Also known as: Enthera Pharmaceuticals, Enthera Srl

Primary location: Milan Italy